Top Edinburgh Healthtech Companies (9)
Don't see your company?
Create a company profile
Best in class BFR exercise equipment, made simple. Portable, gold standard BFR equipment built for professionals
BIOCAPTIVA is developing the BioCaptis, a revolutionary medical device which has the potential to transform liquid biopsy testing for cancer management, by improving early diagnosis and monitoring of disease and enhancing clinical trial data of cancer patients. The BioCaptis captures up to 100x more cell free DNA (cfDNA) than a venous blood draw, yielding cfDNA in high quality and quantity for testing, addressing the major challenge of liquid biopsy in cancer management. This will potentially allow the testing of a far greater number of cancer types and stages in a much wider range of patients. BIOCAPTIVA was founded in 2021 when it spun out from the University of Edinburgh. BIOCAPTIVA is based in Edinburgh and backed by Archangels Scottish Enterprise, Cancer Research Horizons, the new innovation engine of Cancer Research UK and Old College Capital, the University of Edinburgh’s in-house venture investment fund. For more information, please visit www.biocaptiva.com
EnteroBiotix is a leading microbiome therapeutics platform company that is focussed on transforming the standard of care for patients battling debilitating diseases and infections linked to disruptions to structure and function of the gut microbiome
Providing predictive analytics from suspended-cells through our unbiased cytometry technology, Cytomos® Dielectric Spectroscopy: CDS™
InterSystems has been the information engine behind the world's most important applications in healthcare, business and government for over 40 years. Our software products provide advanced data management, integration, and analytics technologies used daily by millions of people in 80+ countries.
We provide a single platform to quickly access and manage a curated marketplace of regulatory approved medical image analysis applications and AI algorithms that add clinical value. Over the past decade, we have worked with leading hospitals, radiology groups, imaging centers and technology providers to deliver automated solutions that help healthcare professionals add clinical value, improve diagnostic confidence and patient outcomes at lower cost. Easily integrated into existing workflows, our unique platform provides actionable information that allows healthcare providers to use imaging information smartly and reduce the cost of care, while improving diagnostic confidence and patient outcomes. The platform’s relevancy engine determines which studies to send each clinical application and results and reports are delivered seamlessly to where they are needed in existing systems
MI:RNA Diagnostics have developed a novel early disease detection technology for the veterinary market that uses microRNA biomarkers to accurately identify if disease is present, through blood sample analysis. By combining this method with an artificial intelligence learning model to enable interpretation, they have adopted a true precision medicine approach. Paving the way, they hope, for many other innovative solutions in this field. It is their mission to reduce disease through research and innovation, resulting in a cascade of ethical, environmental, and economic benefits.
Arrayjet provides microarray instruments and services to the pharmaceutical, diagnostic and life science industries. Our unique inkjet platform combines the fastest and most reliable instrumentation on the market with the versatility to print any biological sample type onto any solid substrate. Applications range from antibody characterization to gene expression profiling and drug discovery. >> High Throughput Screen samples faster with high-speed, high-density, high-capacity microarray printing using patented inkjet technology. >> Consistent Tight environmental controls and real-time quality assurance ensure array reproducibility. >> Cost-Effective Save time and money with increased throughput, lower maintenance requirements, walkaway operation and minimised sample use. Customer relationships drive our innovation. Our technology is cutting edge, but it is our partnerships that deliver long-term value for clients. Get started by booking a technical consultation today. Instruments and services are delivered from our ISO 13485:2016 compliant facility in Scotland
From concept to finished product, we design, develop and distribute market leading LED skincare products under our own brand and as a private label service. Our Award-Winning, clinically-proven products have been designed to offer innovative, easy to use and technically advanced LED Phototherapy treatment available for some of the world’s most common skincare concerns; acne, skin rejuvenation and ageing. Our patented platform technology allows users to ‘wear’ the light delivery device, enabling the treatment to be delivered safely and conveniently. This patented mechanism delivers improved end results through consistency of the light delivery to the skin. With rich clinical heritage, our technical knowledge and IP comes as a result of pioneering work undertaken at the University of St Andrews and Ninewells Hospital Department of Dermatology. Lustre Skin’s technology is clinically proven, and spearheaded by Professor Ifor Samuel, PhD in Physics from Cambridge and Founder of the Organic Semiconductor Centre at St Andrews, and Professor James Ferguson, consultant dermatologist at Ninewells. Our range of LUSTRE ClearSkin products is CE certified indicating conformity with health, safety, and environmental protection standards for products sold within the European Economic Area (EEA). LUSTRE ClearSkin has also been awarded clearance by the US Food and Drug Administration (FDA) for the over-the-counter sale of its LUSTRE ClearSkin system for the treatment of mild to moderate acne, spots and pimples and skincare rejuvenation and MDR application underway. Lustre Skin is an ISO 13485:2016 certified company
Work Your Passion. Live Your Purpose.
